Yvonne Chiu
About Yvonne Chiu
Yvonne Chiu is the Associate Director of Corporate Affairs & Market Access at Bristol Myers Squibb, with extensive experience in market access across multiple regions and a background in pharmacy from National Taiwan University.
Current Role at Bristol Myers Squibb
Yvonne Chiu holds the title of Associate Director of Corporate Affairs & Market Access at Bristol Myers Squibb. She started her current role in April 2020. In this position, she is responsible for managing corporate affairs and market access strategies, focusing on expanding the market reach and ensuring the availability of pharmaceutical products.
Previous Roles at Celgene
Yvonne Chiu worked at Celgene from 2016 to 2020, serving in various key roles in market access. She was the Head of Market Access for Taiwan and ASEAN regions from 2016 to 2020, guiding access strategies across multiple Southeast Asian countries. Additionally, she served as Head of Market Access for Central East Asia, overseeing Taiwan, Hong Kong, Singapore, Thailand, and Malaysia from 2018 to 2020. Her contributions were pivotal in Celgene's regional market reach during her tenure.
Position at Novartis
From 2013 to 2016, Yvonne Chiu worked at Novartis as the Senior Manager, Patient Relations, Policy & Communications. In this role, she managed patient relations, developed policy strategies, and led communications efforts. Her work focused on enhancing patient engagement and shaping communication policies within the pharmaceutical landscape.
Educational Background
Yvonne Chiu earned her Bachelor’s Degree in Pharmacy from National Taiwan University, where she studied from 1993 to 1997. Her academic background in pharmacy has been foundational to her extensive career in market access and corporate affairs within the pharmaceutical industry.
Extensive Experience in Market Access
With a career spanning multiple prominent pharmaceutical companies, Yvonne Chiu has extensive experience in market access strategies. She has worked across various regions, including Central East Asia, Taiwan, Hong Kong, Singapore, Thailand, and Malaysia. Her expertise has been instrumental in driving market expansion and ensuring the availability of medical products in diverse markets.